DAEJEON, Jul. 12 (Korea Bizwire) — A ‘Next Generation Korean Dielectric Analysis System’ will be established to reduce the cost of dielectric analysis, which helps manage various diseases.
The Korea Research Institute of Bioscience and Biotechnology (KRIBB) announced on Thursday that it was selected for the government project to develop a new dielectric analysis system.
For the project, the Ministry of Trade, Industry and Energy, jointly with the city of Daejeon, will invest 14 billion won (US$11.8 million) by 2022.
Researchers at KRIBB will begin developing cutting-edge devices for DNA sequencing and analysis that will be used to process a large amount of dielectric data, which will allow cheap and expedited production of dielectric information.
The research team will also build a computing system that will store and manage dielectric data, as well as a pipeline and interpretation system that analyses dielectric data that includes the sequencing of whole-genomes, exomes, transcriptomes, and metagenomes produced based on various forms of diseases.
“Dielectric interpretation technology is essential for tailored disease control and detailed treatment,” said Dr. Kim Seon-young at the KRIBB Metabolic Regulation Research Center.
“The current cost of analyzing the human genome remains at US$1,000. We hope that this project can reduce the cost and lead to the development of next-generation gene sequencing technology.”
Kevin Lee (firstname.lastname@example.org)